HUTCHMED (China) (HCM) EBIT Margin: 2018-2021

Historic EBIT Margin for HUTCHMED (China) (HCM) over the last 3 years, with Dec 2021 value amounting to -172.21%.

  • HUTCHMED (China)'s EBIT Margin was N/A to -172.21% in Q4 2021 from the same period last year, while for Dec 2021 it was 33.17%, marking a year-over-year change of. This contributed to the annual value of -6.94% for FY2024, which is 1166.00% down from last year.
  • As of Q4 2021, HUTCHMED (China)'s EBIT Margin stood at -172.21%, which was down 159.37% from 290.05% recorded in Q2 2021.
  • In the past 5 years, HUTCHMED (China)'s EBIT Margin ranged from a high of 617.12% in Q2 2019 and a low of -1,048.84% during Q4 2019.
  • Its 3-year average for EBIT Margin is 75.53%, with a median of 264.40% in 2019.
  • Over the last 5 years, HUTCHMED (China)'s EBIT Margin had its largest YoY gain of 99,455bps in 2019, and its largest YoY loss of 99,565bps in 2019.
  • Over the past 4 years, HUTCHMED (China)'s EBIT Margin (Quarterly) stood at -53.19% in 2018, then slumped by 99,565bps to -1,048.84% in 2019, then slumped by 33,995bps to 277.17% in 2020, then spiked by 1,288bps to -172.21% in 2021.
  • Its EBIT Margin was -172.21% in Q4 2021, compared to 290.05% in Q2 2021 and 270.46% in Q1 2021.